This is the authors' abstract. We don't add key points for this paper.
Background: The gold standard for the diagnosis of celiac disease (CD) is an upper GI endoscopy (EGD) with intestinal biopsy. Aims: To establish the true sensitivity, specificity, positive (PPV) and negative (NPV) predicted values of a combination of serological tests for CD using an intestinal biopsy as a gold standard. The overall goal was to develop a CD serology tests algorithm that can avoid an intestinal biopsy for confirmation of CD. Methods: Sixty-eight consecutive patients referred by the Small Bowel disorders clinic to EGD and intestinal biopsy because of CD-related symptoms were enrolled between August 2004 and July 2005 (Group A). During the same period, a random sample of patients (n = 98) undergoing to an EGD for symptoms or disorders not related to CD was also enrolled (Group B). All duodenal biopsies were blindly scored using the modified Marsh criteria. At the time of the procedure, a serum sample was also obtained to check for serum anti-actin antibodies (AAA), anti- tissue transglutaminase antibodies (TTG), and zonulin levels. Results: Thirty-three of the 68 patients from group A (48%) and 1/98 (1%) from group B showed histological findings compatible with CD (Marsh IIIa-IIIc). Of the 34 CD patients identified, 27 tested positive to all three tests, 4 tested positive to TTG and zonulin, and 3 tested positive to zonulin alone. The combination of AAA, TTG, and zonulin tests showed a sensitivity of 79%, a PPV of 100%, and a NPV of 100%. Conclusions: Subjects experiencing malabsorptive symptoms, the combination of positive AAA, TTG, and zonulin can be used to rule in CD without the necessity to perform an EGD. This approach would have allowed avoiding an invasive procedure in 38% of the cases of malabsorption enrolled, an approach that could translate in cost saving and better patient's acceptance. The combination of negative AAA, TTG, and zonulin rules out CD.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kryszak et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: